Pharmaceutical

Filter

Current filters:

None

Popular Filters

151 to 175 of 7041 results

CRO Parexel sees CRF Health and Clinical Ink join it Perceptive Partner Program

11-09-2014

USA-headquartered Parexel International, a leading global biopharmaceutical services organization, today…

Clinical InkCRF HealthParexelPharmaceuticalResearch

Sophia Genetics in deal with Britain's NHS, and a leading Turkish lab

11-09-2014

Sophia Genetics, a European leader in data driven medicine, has significantly expanded its European customer…

PharmaceuticalProductionResearchSophia GeneticsTurkeyUK

New indication for Astellas/Medivation’s Xtandi from US FDA

New indication for Astellas/Medivation’s Xtandi from US FDA

11-09-2014

The US Food and Drug Administration has approved a new indication for the use of Japanese drug major…

Astellas PharmaMedivationOncologyPharmaceuticalResearchUSAXtandi

Indian clinical trial rules counter-productive, says ASSOCHAM

Indian clinical trial rules counter-productive, says ASSOCHAM

10-09-2014

The Associated Chambers of Commerce and Industry of India (ASSOCHAM ) has expressed concern at the setback…

IndiaPharmaceuticalPoliticsRegulationResearch

New Gilenya data confirm reducing brain shrinkage matters for people with MS

10-09-2014

Swiss pharma giant Novartis has presented new data at the joint ACTRIMS-ECTRIMS meeting in Boston, USA,…

GilenyaNeurologicalNovartisPharmaceuticalResearch

ERS 2014: Positive new data on Boehringer’s nintedanib in IPF patients

ERS 2014: Positive new data on Boehringer’s nintedanib in IPF patients

10-09-2014

A pre-specified subgroup analysis from the two replicate Phase III INPULSI trials, presented today at…

Boehringer IngelheimnintedanibPharmaceuticalResearchRespiratory and Pulmonary

FDA Advisory votes against approving Actavis nebivolol/valsartan combo

FDA Advisory votes against approving Actavis nebivolol/valsartan combo

10-09-2014

Ireland-based generic drug major Actavis yesterday confirmed that the US Food and Drug Administration's…

ActavisCardio-vascularnebivololPharmaceuticalRegulationUSAvalsartan

Oliver Siegel appointed chief operating officer at AFFiRiS

Oliver Siegel appointed chief operating officer at AFFiRiS

09-09-2014

Oliver Siegel has been appointed as chief operating officer at Austrian vaccine specialist AFFiRiS AG,…

AFFiRiSAustriaBoardroomChronic diseasesOliver SiegelPharmaceuticalVaccine specialist

GSK joins with research councils in UK and South Africa to tackle non-communicable diseases in Africa

GSK joins with research councils in UK and South Africa to tackle non-communicable diseases in Africa

09-09-2014

UK pharma giant GlaxoSmithKline today announced a £5 million ($8.2 million) collaboration with the UK…

FinancialGlaxoSmithKlinePharmaceuticalResearchSouth AfricaUK

China tops pharmaceutical material suppliers for Vietnam

China tops pharmaceutical material suppliers for Vietnam

08-09-2014

China is the largest supplier of pharmaceutical materials for Vietnam in the first seven months of 2014,…

AsiaAustriaBusiness FinanceChinaIndiaMarkets & MarketingPharmaceuticalVietnamXinhua

Meiji and Takeda to co-promote Rozerem for insomnia

Meiji and Takeda to co-promote Rozerem for insomnia

08-09-2014

Fellow Japanese drugmakers Meiji Seika Pharma and Takeda Pharmaceutical have finalized a co-promotion…

JapanLicensingMeiji Seika PharmaNeurologicalPharmaceuticalRozeremTakeda Pharmaceutical

Roche’s RoActemra gains EU approval for use in early RA

Roche’s RoActemra gains EU approval for use in early RA

08-09-2014

The European Commission has approved Swiss pharma major Roche’s RoActemra (tocilizumab) for use in…

ActemraAnti-Arthritics/RheumaticsEuropeInterleukin 6PharmaceuticalRegulationRoActemraRoche

151 to 175 of 7041 results

Back to top